Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs United States Copper Index Fund (CPER) Price & Performance

Amgen, Inc.Trade
United States Copper Index FundTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs United States Copper Index Fund — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while United States Copper Index Fund trades at $40.55. The key difference: Amgen, Inc. pays a 2.43% dividend while United States Copper Index Fund pays none. Which is the better fit depends on your goals.

AMGNCPER
Market Cap
$224.14B
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$417.20$40.85
52-Week Low
$271.18$27.57
Enterprise Value
$267.45B
Dividend Yield
2.43%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About United States Copper Index Fund

CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.

Read more on CPER